Anika Therapeutics Organic Growth Can’t Offset Viscosupplement Declines Company Revenue The Numbers The company declined in the mid-single digits due to COVID-related headwinds and inventory stocking declines in its orthobiologics franchise. May 11, 2021
OrthoPediatrics Takes Share to Open 2021 Company Revenue The Numbers The company grew 31% in the first quarter of 2021, hitting double-digit growth even with ten-year-old products. May 11, 2021
Conformis Near-Term Growth Hinges on Intellectual Property Company Revenue The Numbers The company declined in the mid-teens for 1Q21 but hopes to return to product revenue growth above 2019-levels by the end of the year. May 10, 2021
ATEC Marks Tenth Consecutive Quarter of Double-Digit Growth in 1Q21 Company Revenue The Numbers The company grew 45% in 1Q21 despite surgical volume pressure in January and February as ATEC continues to drive conversion and uptake. May 10, 2021
NuVasive Benefits from International Recovery in 1Q21 Company Revenue The Numbers The company grew in the mid-single-digits for the first quarter, as recovery in global markets offset some choppiness in the U.S. May 07, 2021
Vericel Raises MACI Guidance on Record First Quarter Company Revenue The Numbers The company’s MACI business grew nearly +20% in the first quarter of 2021 as Vericel continues to broaden its surgeon user base. May 07, 2021
Zimmer Biomet Continues Technology Evolution in First Quarter Company Revenue The Numbers The company grew in the low single-digits for 1Q21, with important contributions from ROSA and its Signature ONE shoulder planner. May 06, 2021
Globus Medical Takes More Share in First Quarter Company Revenue The Numbers The company’s spine business grew over 20% in the first quarter, driven by robotic pull-through, new products and competitive recruiting. May 06, 2021
SeaSpine’s First Quarter Growth Fueled by Volume Gains Company Revenue The Numbers The company grew in the mid-teens for 1Q21, driven by new product launches and geographic expansion in the U.S. May 05, 2021
SI-BONE Rides Record March Revenues for First Quarter Growth Company Revenue The Numbers The company realized around 40% of its first-quarter sales in March to overcome COVID and weather-related declines for 1Q21. May 05, 2021